WING-KEI CHIU: Open Payments
NPI 1205596111 · EULESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 66 payments from 18 companies in 2025. Trend: 2023 $734 · 2024 $934 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $136 |
| ABBVIE INC. | 7 | $123 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| E.R. Squibb & Sons, L.L.C. | 5 | $102 |
| Alkermes, Inc. | 4 | $87 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, COBENFY, ARISTADA, Auvelity, SPRAVATO.
Industry payments across TX — which companies pay providers there.
